Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed Changes.
Journal of clinical psychopharmacology · 2025 · 31 citations · Justin Faden
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
Journal of clinical psychopharmacology · 2025 · 29 citations · Justin Faden
Schizophrenia: One Name, Many Different Manifestations.
The Medical clinics of North America · 2023 · 65 citations · Justin Faden
A systematic review of clozapine for aggression and violence in patients with schizophrenia or schizoaffective disorder.
Schizophrenia research · 2024 · 30 citations · Justin Faden
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder.
Expert review of neurotherapeutics · 2024 · 16 citations · Justin Faden
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions.
Pharmacogenomics and personalized medicine · 2023 · 24 citations ·
A Web- and Mobile-Based Intervention for Women Treated for Breast Cancer to Manage Chronic Pain and Symptoms Related to Lymphedema: Results of a Randomized Clinical Trial.
JMIR cancer · 2022 · 31 citations · Nardin El-Shammaa
Asenapine: an atypical antipsychotic with atypical formulations.
Therapeutic advances in psychopharmacology · 2021 · 23 citations · Justin Faden